Risk factors and prognosis of nosocomial bloodstream infections caused by extended-spectrum-β-lactamase-producing Escherichia coli

Journal of Clinical Microbiology

Volumn 48, Issue 5, 2010, Pages 1726-1731

  Rodríguez Baño, Jesús ^a,b   Picón, Encarnación ^a   Gijón, Paloma ^c   Hernández, José Ramón ^a   Cisneros, Jose M ^d   Peña, Carmen ^e   Almela, Manuel ^f   Almirante, Benito ^g   Grill, Fabio ^h,o   Colomina, Javier ⁱ   Molinos, Sonia ^j   Oliver, Antonio ^k   Fernández Mazarrasa, Carlos ^l   Navarro, Gemma ^m   Coloma, Ana ⁿ   López Cerero, Lorena ^a,b   Pascual, Alvaro ^a,b  

^a HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

^b UNIVERSITY OF SEVILLE   (Spain)

^c HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^d HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^e HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^f HOSPITAL CLÍNIC   (Spain)

^g HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^h HOSPITAL RAMÓN Y CAJAL   (Spain)

ⁱ Hospital Universitario de la Ribera   (Spain)

^j HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^k HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^l HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^m Hospital Universitari Parc Taulí   (Spain)

ⁿ HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^o HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CEPHALOSPORIN; EXTENDED SPECTRUM BETA LACTAMASE; PENICILLIN G;

AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; BLOODSTREAM INFECTION; CONTROLLED STUDY; ESCHERICHIA COLI; FEMALE; GRAFT REJECTION; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; INFECTION RISK; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SCORING SYSTEM; SPAIN;

ESCHERICHIA COLI;

EID: 77951811232     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.02353-09     Document Type: Article

References (33)

1. Albrecht, S. J., N. O. Fishman, J. Kitchen, I. Nachamkin, W. B. Bilker, C. Hoegg, C. Samel, S. Barbagallo, J. Arentzen, and E. Lautenbach. 2006. Reemergence of gram-negative health care-associated bloodstream infections. Arch. Intern. Med. 166:1289-1294.
2. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee. 1992. Definitions for sepsis and organ failure and guidelines for use of innovative therapies in sepsis. Crit. Care Med. 20:864-874.
3. Ben-Ami, R., A. Leavitt, M. J. Schwaber, S. Navon-Venezia, D. Schwartz, M. Giladi, I. Chmelnitsky, and Y. Carmeli. 2006. Influx of extended-spectrum beta-lactamase-producing Enterobacteriaceae into the hospital. Clin. Infect. Dis. 42:925-934.
4. Charlson, M. E., P. Pompei, K. L. Ales, and C. R. MacKenzie. 1987. A new method of classifying prognostic co-morbidity in longitudinal studies: development and validation. J. Chron. Dis. 40:373-383.
5. Clermont, O., S. Bonacorsi, and E. Bingen. 2000. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl. Environ. Microbiol. 66:4555-4558.
6. Clermont, O., M. Lavollay, S. Vimont, C. Deschamps, C. Forestier, C. Branger, E. Denamur, and G. Arlet. 2008. The CTX-M-15-producing Escherichia coli diffusing clone belongs to a highly virulent B2 phylogenetic subgroup. J. Antimicrob. Chemother. 61:1024-1028.
7. Clermont, O., H. Dhanji, M. Upton, T. Gibreel, A. Fox, D. Boyd, M. R. Mulvey, P. Nordmann, E. Ruppé, J. L. Sarthou, T. Frank, S. Vimont, G. Arlet, C. Branger, N. Woodford, and E. Denamur. 2009. Rapid detection of the O25b-ST131 clone of Escherichia coli encompassing the CTX-M-15-producing strains. J. Antimicrob. Chemother. 64:274-277.
8. Clinical and Laboratory Standards Institute. 2005. Performance standards for antimicrobial susceptibility testing: 15th informational supplement. Approved standard M100-S14. Clinical and Laboratory Standards Institute, Wayne, PA.
9. Feil, E. J., and M. C. Enright. 2004. Analyses of clonality and the evolution of bacterial pathogens. Curr. Opin. Microbiol. 7:308-313.
10. García-Prado, E., E. Cordero, J. M. Alamo, M. A. Gómez, J. M. Pascasio, M. Sánchez, and J. M. Cisneros. 2009. Descriptive study of infectious complications in 109 consecutive liver transplant recipients. Enferm. Infecc. Microbiol. Clin. 27:199-205.
11. García-Prado, M. E., E. Cordero, V. Cabello, P. Pereira, F. J. Torrubia, M. Ruíz, and J. M. Cisneros. 2009. Infectious complications in 159 consecutive kidney transplant recipients. Enferm. Infecc. Microbiol. Clin. 27:22-27.
12. Harris, A. D., T. B. Karchmer, Y. Carmeli, and S. H. Samore. 2001. Methodological principles of case-control studies that analysed risk factors for antibiotic resistance: a systematic review. Clin. Infect. Dis. 32:1055-1061.
13. Linares, L., J. F. García-Goez, C. Cervera, M. Almela, G. Sanclemente, F. Cofán, M. J. Ricart, M. Navasa, and A. Moreno. 2009. Early bacteremia after solid organ transplantation. Transplant. Proc. 41:2262-2264.
14. Miró, E., B. Mirelis, F. Navarro, A. Rivera, and R. Mesa. 2005. Surveillance of extended spectrum β-lactamases from clinical samples and faecal carriers in Barcelona, Spain. J. Antimicrob. Chemother. 56:1152-1155.
15. Nicolas-Chanoine, M. H., J. Blanco, V. Leflon-Guibout, R. Demarty, M. P. Alonso, M. M. Caniça, Y. J. Park, J. Pitout, and J. R. Johnson. 2008. Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. J. Antimicrob. Chemother. 61:273-281.
16. Ortega, M., F. Marco, A. Soriano, M. Almela, J. A. Martínez, A. Muñoz, and J. Mensa. 2009. Analysis of 4758 Escherichia coli bacteraemia episodes: predictive factors for isolation of an antibiotic resistant strain and their impact on outcome. J. Antimicrob. Chemother. 63:568-574.
17. Oteo, J., C. Navarro, E. Cercenado, A. Delgado-Iribarren, I. Wilhelmi, B. Orden, C. García, S. Miguelañez, M. Pérez-Vázquez, S. García-Cobos, B. Aracil, V. Bautista, and J. Campos. 2006. Spread of Escherichia coli strains with high-level cefotaxime and ceftazidime resistance between the community, long-term care facilities, and hospital institutions. J. Clin. Microbiol. 44:2359-2366.
18. Paterson, D. L., and R. A. Bonomo. 2005. Extended-spectrum β-lactamases: a clinical update. Clin. Microbiol. Rev. 18:657-686.
19. Peralta, G., M. B. Sánchez, J. C. Garrido, I. de Benito, M. E. Cano, L. Martínez-Martínez, and M. P. Roiz. 2007. Impact of antibiotic resistance and adequate empirical antibiotic treatment in the prognosis of patients with Escherichia coli bacteraemia. J. Antimicrob. Chemother. 60:855-863.
20. Pitout, J. D. D., and K. B. Laupland. 2008. Extended-spectrum β-lactamaseproducing Enterobacteriaceae: an emerging public health concern. Lancet Infect. Dis. 8:159-166.
21. Rodríguez-Baño, J., J. C. Alcalá, J. M. Cisneros, F. Grill, A. Oliver, J. P. Horcajada, T. Tórtola, B. Mirelis, G. Navarro, M. Cuenca, M. Esteve, C. Peña, A. C. Llanos, R. Cantón, and A. Pascual. 2008. Community infections caused by extended spectrum ß-lactamase-producing Escherichia coli. Arch. Intern. Med. 168:1807-1902.
22. Rodríguez-Baño, J., L. López-Cerero, M. D. Navarro, P. Díaz de Alba, and A. Pascual. 2008. Faecal carriage of extended-spectrum β-lactamase-producing Escherichia coli: prevalence, risk factors and molecular epidemiology. J. Antimicrob. Chemother. 62:1142-1149.
23. Rodríguez-Baño, J., M. D. López-Prieto, M. M. Portillo, P. Retamar, C. Natera, E. Nuño, M. Herrero, A. del Arco, A. Muñoz, F. Téllez, M. Torres-Tortosa, A. Martín-Aspas, A. Arroyo, A. Ruiz, R. Moya, J. E. Corzo, L. León, and J. A. Pérez-López on behalf of the SAEI/SAMPAC Bacteraemia Group. 20 October 2009. Epidemiology and clinical features of community-acquired, healthcare associated and nosocomial bloodstream infections in tertiary and community hospitals. Clin. Microbiol. Infect. [Epub ahead of print.]
24. Rodríguez-Baño, J., M. D. Navarro, L. Romero, M. A. Muniain, M. de Cueto, M. J. Ríos, J. R. Hernández, and A. Pascual. 2006. Bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli in the CTX-M era: a new clinical challenge. Clin. Infect. Dis. 43:1407-1414.
25. Rodríguez-Baño, J., M. D. Navarro, L. Romero, M. A. Muniain, E. J. Perea, R. Pérez-Cano, J. R. Hernández, and A. Pascual. 2006. Clinical and molecular epidemiology of extended-spectrum beta-lactamase-producing Escherichia coli as a cause of nosocomial infection or colonization: implications for control. Clin. Infect. Dis. 42:37-45.
26. Rodríguez-Baño, J., and A. Pascual. 2008. Clinical significance of extended-spectrum β-lactamases. Expert Rev. Anti Infect. Ther. 6:671-683.
27. Rodríguez-Baño, J., E. Picón, P. Gijón, J. R. Hernández, M. Ruíz, C. Peña, M. Almela, B. Almirante, F. Grill, J. Colomina, M. Giménez, A. Oliver, J. P. Horcajada, G. Navarro, A. Coloma, and A. Pascual for the Spanish Network for Research in Infectious Diseases (REIPI). 2010. Community-onset bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli: risk factors and prognosis. Clin. Infect. Dis. 50:40-48.
28. Rodriguez-Créixems, M., L. Alcalá, P. Muñoz, E. Cercenado, T. Vicente, and E. Bouza. 2009. Bloodstream infections. Evolution and trends in the microbiology workload, incidence and etiology, 1985-2006. Medicine 87:234-249.
29. Safdar, N., and D. G. Maki. 2002. The commonality of risk factors for nosocomial colonization and infection with antimicrobial-resistant Staphylococcus aureus, Enterococcus, gram-negative bacilli, Clostridium difficile, and Candida. Ann. Intern. Med. 136:834-844.
30. Schwaber, M. J., and Y. Carmeli. 2007. Mortality and delay in effective therapy associated with extended-spectrum β-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis. J. Antimicrob. Chemother. 60:913-920.
31. Vila, J., M. A. Marcos, and M. T. Jiménez de Anta. 1996. A comparative study of different PCR-based DNA fingerprinting techniques for typing of the Acinetobacter calcoaceticus-A. baumannii complex. J. Med. Microbiol. 44:482-489.
32. von Elm, E., D. G. Altman, M. Egger, S. J. Pocock, P. C. Gøtzsche, and J. P. Vandenbroucke for the STROBE Initiative. 2008. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. J. Clin. Epidemiol. 61:344-349.
33. Wisplinghoff, H., T. Bischoff, S. M. Tallent, H. Seifert, R. P. Wenzel, and M. B. Edmond. 2004. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin. Infect. Dis. 39:309-317.